National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

bispecific antibody 2B1
A monoclonal antibody with potential antineoplastic activity. Specific for both the immunoglobulin G (IgG) receptor CD16 and c-erbB-2, bispecific antibody 2B1 may enhance cellular immune responses against c-erbB-2-positive cells, resulting in increased tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:2B1
2B1 antibody, bispecific
2B1 Bispecific MAb
2B1 Bispecific Murine MAb
MoAb 2B1 Bispecific
Abbreviation:BsAb 2B1



Previous:BioResponse DIM, biricodar dicitrate, bisantrene hydrochloride, bismuth Bi213 monoclonal antibody M195, bismuth subsalicylate
Next:bispecific antibody 4G7xH22, bispecific antibody MDX-H210, bispecific antibody MDX447, bizelesin, BL22 immunotoxin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov